ME/CFS AUSTRALIA (SA) INC Registered Charity 698 Mailing address: GPO Box 383, Adelaide, South Australia 5001 Office: 266 Port Road, Hindmarsh, South Australia 5007 Ph: (08) 8346 3237 ('834 MECFS') Office Hours: Wednesdays, 10am-3pm Support Line: (Mondays and Thursdays, 10am-3pm) Ph: (08) 8346 3237 SA country callers: Ph: 1300 128 339 (local call)
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
Disclaimer ME/CFS Australia (SA) Inc aims to keep members informed of the various research projects, diets, medications, therapies etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives. Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services. |
In the News – 2007 |
|||||||||||||
New Research ProjectLooking for a specific gene mutation that may cause ME/CFSRecently, we have discovered a mutation in a specific gene. This mutation causes chronic fatigue. It is possible that this mutation exists in people with Chronic Fatigue Syndrome since many standard clinical tests would not show any marked abnormality. Hence, we wish to test to find if this mutation may be the cause of CFS in some people. The study is important because it may allow for a treatment to compensate for absence of the protein due to the mutation in those chronic fatigue sufferers who have the mutation. This will, however, require further study in the affected individuals. We wish to offer testing for this mutation and a related protein in blood following a single blood test taken in the early morning (before 9:00am). We also wish you to complete a questionnaire regarding fatigue and your medical history, if you consent to the study. The results of testing will be sent to you by mail as soon as possible. Those who test positive for the mutation will be invited to meet one of the physicians involved in the study for an interview. Results will be made available only to the individual tested and not to any other individual. Your confidentiality will be closely respected. If you may be interested in participating in the study, please contact us and register your interest. We will send you a package containing instructions on having a blood sample taken at your local pathology collection centre, as well as a consent form for you to sign. Contact details(When you contact us, please leave your name and mailing address)
|
||||||||||||||